2019 Probiotic Supplements Market Trends, Size - Industry Report 2019-2026
  • Home
  • Foods & Beverage
  • Get all Foods and Beverages Industry Market Research Reports from Market Expertz
 
  • Global Probiotic Supplements Market (2018 - 2027)

    ID :  ME_047187 Format :   PDF August, 2019 Pages :  143
     
  • Get 15% free customization on this report
The global probiotic supplements market is projected to expand at a compound annual growth rate (CAGR) of 10.43%, and will reach USD 3.28 Bn by 2027. Awareness about health and fitness is augmenting the need for nutritional diets and maintenance of healthy microbiota, thereby propelling the demand for probiotic supplements.
Form segment insights:
Probiotics are consumed mostly in dry form as capsules, powder, chewable, and tablets. The rising adoption of gummies and chewable probiotic supplements is expected to increase the growth of the dry probiotics market across the world. The dry probiotic supplements segment held a market share of 83% in 2017. The development of dry probiotic supplements for chronic diseases will fuel the growth of the segment, at an expected CAGR of 10.15% during the 2018-2027 period.
Source segment insights:
Based on the source, the market was dominated by the bacteria-based probiotic supplements segment, with a 91% share in 2017. Most probiotic supplements include bacterial strains, of which, Lactobacillus sp and Bifidobacterium sp are used widely for the maintenance of healthy microbiota.
Distribution channel segment insights:
The pharmacy store-based probiotic supplements segment was the leading contributor to the global probiotic supplements market, having generated 46% of the market value in 2017. However, the online store-based probiotic supplements segment is expected to witness the highest expansion, at a CAGR of 13.49% during the 2018-2027 period. The key online distribution channels for probiotic supplements include Amazon, Costco, and The Vitamin Shoppe, among others.
Application segmentation insights:
The segment for gastrointestinal health will be the leading contributor to the global probiotic supplements market, and is anticipated to contribute approximately 64% to the global market value by 2027. The reason for being the leading application segment can be attributed to the increasing prevalence of digestive diseases and diarrhea, due to changing food habits and lifestyle, especially in developing countries.
Regional insights:
The North America probiotic supplements market is projected to expand at a CAGR of 10.68% during the 2018-2027 period, leading to a global revenue of USD 1483.1 Mn by 2027. Increasing awareness about the benefits of probiotic supplements, and inclinations towards preventive care will aid the growth of the market. The Asia-Pacific probiotic supplements market is expected to expand at the highest CAGR of 11.34% between 2018 and 2027.
Companies covered:


Chapter 1: Executive summary
1.1. Market scope and segmentation
1.2. Key questions answered in this study
1.3. Executive summary - I
1.4. Executive summary - II


Chapter 2: Global probiotic supplements market - overview
2.1. Global market overview - market trends, market attractiveness analysis, geography-wise market revenue (USD Mn)
2.2. Global market drivers and challenges
2.3. Value chain analysis
2.4. Porter's five forces analysis
2.5. Strategic imperatives for success and growth
2.6. Market size - based on source (bacteria and yeast)
2.6. a. Bacteria - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.5. 6. Yeast - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

2.7. Market size - based on form (liquid, dry [capsules, chewable, tablets, powder, and others])
2.7. a. Liquid - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.7. b. Dry - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.7. b.i. Capsules - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.7. b.ii. Chewable - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.7. b.iii. Tablets - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.7. b.iv. Powder - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.7. b. v. Others - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations


2.8. Market size - based on distribution channel (pharmacy, hypermarkets/supermarkets, online sales, specialty stores, and direct sales)
2.8. a. Pharmacy - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.8. b. Hypermarkets/supermarkets - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.8. c. Online sales - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.8. d. Specialty stores - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.8. e. Direct sales - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

2.9. Market size - based on application (gastrointestinal health, immune health, vaginal health, urinary tract health, oral health, and others)
2.9. a. Gastrointestinal health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.9. b. Immune health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.9. c. Vaginal health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.9. d. Urinary tract health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.9. e. Oral health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.9. f. Others - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

Chapter 3: North America probiotic supplements market - overview
3.1. Market overview - market trends, market attractiveness analysis, geography-wise market revenue (USD Mn)
3.2. North America market drivers and challenges
3.3. Market size - based on source (bacteria and yeast)
3.3. a. Bacteria - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.3. b. Yeast - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

3.4. Market size - based on form (liquid, dry [capsules, chewable, tablets, powder, and others])
3.4. a. Liquid - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.4. b. Dry - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.4. b.i. Capsules - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.4. b.ii. Chewable - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.4. b.iii. Tablets - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.4. b.iv. Powder - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.4. b.v. Others - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

3.5. Market size - based on distribution channel (pharmacy, hypermarkets/supermarkets, online sales, specialty stores, and direct sales)
3.5. a. Pharmacy - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.5. b. Hypermarkets/supermarkets - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.5. c. Online sales - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.5. d. Specialty stores - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.5. e. Direct sales - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

3.6. Market size - based on application (gastrointestinal health, immune health, vaginal health, urinary tract health, oral health, and others)
3.6. a. Gastrointestinal health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.6. b. Immune health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.6. c. Vaginal health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.6. d. Urinary tract health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.6. e. Oral health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.6. f. Others - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations


Chapter 4: Europe probiotic supplements market - overview
4.1. Market overview- market trends, market attractiveness analysis, geography-wise market revenue (USD Mn)
4.2. Europe market drivers and challenges
4.3. Market size - based on source (bacteria and yeast)
4.3. a. Bacteria - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.3. b. Yeast - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

4.4. Market size - based on form (liquid, dry [capsules, chewable, tablets, powder, and others])
4.4. a. Liquid - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.4. b. Dry - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.4. b.i. Capsules - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.4. b.ii. Chewable - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.4. b.iii. Tablets - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.4. b.iv. Powder - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.4. b.v. Others - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

4.5. Market size - based on distribution channel (pharmacy, hypermarkets/supermarkets, online sales, specialty stores, and direct sales)
4.5. a. Pharmacy - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.5. b. Hypermarkets/supermarkets - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.5. c. Online sales - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.5. d. Specialty stores - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.5. e. Direct sales - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

4.6. Market size - based on application (gastrointestinal health, immune health, vaginal health, urinary tract health, oral health, and others)
4.6. a. Gastrointestinal health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.6. b. Immune health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.6. c. Vaginal health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.6. d. Urinary tract health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.6. e. Oral health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.6. f. Others - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations


Chapter 5: Asia-Pacific probiotic supplements market - overview
5.1. Market overview- market trends, market attractiveness analysis, geography-wise market revenue (USD Mn)
5.2. Asia-Pacific market drivers and challenges
5.3. Market size - based on source (bacteria and yeast)
5.3. a. Bacteria - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.3. b. Yeast - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

5.4. Market size - based on form (liquid, dry [capsules, chewable, tablets, powder, and others])
5.4. a. Liquid - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.4. b. Dry - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.4. b.i. Capsules - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.4. b.ii. Chewable - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.4. b.iii. Tablets - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.4. b.iv. Powder - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.4. b.v. Others - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

5.5. Market size - based on distribution channel (pharmacy, hypermarkets/supermarkets, online sales, specialty stores, and direct sales)
5.5. a. Pharmacy - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.5. b. Hypermarkets/supermarkets - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.5. c. Online sales - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.5. d. Specialty stores - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.5. e. Direct sales - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

5.6. Market size - based on application (gastrointestinal health, immune health, vaginal health, urinary tract health, oral health, and others)
5.6. a. Gastrointestinal health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.6. b. Immune health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.6. c. Vaginal health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.6. d. Urinary tract health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.6. e. Oral health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.6. f. Others - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

Chapter 6: Latin America probiotic supplements market - overview
6.1. Market overview- market trends, market attractiveness analysis, geography-wise market revenue (USD Mn)
6.2. Latin America market drivers and challenges
6.3. Market size - based on source (bacteria and yeast)
6.3. a. Bacteria - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.3. b. Yeast - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

6.4. Market size - based on form (liquid, dry [capsules, chewable, tablets, powder, others])
6.4. a. Liquid - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.4. b. Dry - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.4. b.i. Capsules - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.4. b.ii. Chewable - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.4. b.iii. Tablets - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.4. b.iv. Powder - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.4. b.v. Others - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

6.5. Market size - based on distribution channel (pharmacy, hypermarkets/supermarkets, online sales, specialty stores, and direct sales)
6.5. a. Pharmacy - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.5. b. Hypermarkets/supermarkets - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.5. c. Online sales - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.5. d. Specialty stores - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.5. e. Direct sales - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

6.6. Market size - based on application (gastrointestinal health, immune health, vaginal health, urinary tract health, oral health, and others)
6.6. a. Gastrointestinal health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.6. b. Immune health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.6. c. Vaginal health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.6. d. Urinary tract health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.6. e. Oral health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.6. f. Others - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations


Chapter 7: The Middle East and Africa probiotic supplements market - overview
7.1. Market overview- market trends, market attractiveness analysis, geography-wise market revenue (USD Mn)
7.2. The Middle East and Africa market drivers and challenges
7.3. Market size - based on source (bacteria and yeast)
7.3. a. Bacteria - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.3. b. Yeast - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

7.4. Market size - based on form (liquid, dry [capsules, chewable, tablets, powder, and others])
7.4. a. Liquid - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.4. b. Dry - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.4. b.i. Capsules - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.4. b.ii. Chewable - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.4. b.iii. Tablets - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.4. b.iv. Powder - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.4. b.v. Others - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

7.5. Market size - based on distribution channel (pharmacy, hypermarkets/supermarkets, online sales, specialty stores, and direct sales)
7.5. a. Pharmacy - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.5. b. Hypermarkets/supermarkets - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.5. c. Online sales - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.5. d. Specialty stores - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.5. e. Direct sales - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

7.6. Market size - based on application (gastrointestinal health, immune health, vaginal health, urinary tract health, oral health, and others)
7.6. a. Gastrointestinal health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.6. b. Immune health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.6. c. Vaginal health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.6. d. Urinary tract health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.6. e. Oral health - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.6. f. Others - historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations


Chapter 8: Competitive landscape
8.1. Market share of key companies
8.2. Sanofi
8.1.a. Company snapshot
8.1.b. Product offerings
8.1.c. Strategic initiatives
8.1.d. Geographical presence
8.1.e. Key numbers
8.3. The Procter & Gamble Company
8.4. Novartis
8.5. i-Health, Inc.
8.6. Taisho Pharmaceutical Holdings Co., Ltd.
8.7. BioGaia
8.8. Bayer Group
8.9. Probi AB
8.10. RENEW LIFE
8.11. Danisco A/S


Chapter 9: Conclusion

Chapter 10: Appendix
10.1. List of tables
10.2. Research methodology
10.3. Assumptions
10.4. About Netscribes Inc.

A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.

Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.

Now let’s take a closer look at the research methods here.

Secondary Research Model:

Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.

Primary Insights:

Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.

However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.

Market Estimation:

The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.

Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.

Final Presentation:

The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.

 
Related Reports
 

© Marketexpertz   |   All Rights Reserved 2019